<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33492">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01893619</url>
  </required_header>
  <id_info>
    <org_study_id>immunoprop</org_study_id>
    <nct_id>NCT01893619</nct_id>
  </id_info>
  <brief_title>Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome</brief_title>
  <acronym>immunoprop</acronym>
  <official_title>Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York CFS Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York CFS Association</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational study regarding the use of supplements in chronic fatigue syndrome patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Detailed questionnaire regarding the diagnosis of an onset of chronic fatigue syndrome and
      100 patients. using Karnofsky scale before and after use of supplements patient scores are
      compared in a double blind trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Karnovsky score comparison</measure>
    <time_frame>Six months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Review of Karnofsky score over prior to diagnosis and subsequent to patients having taken supplements</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Chronic Fatigue Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Fukuda criteria and Canadian consensus criteria will be the diagnosis criteria for patient
        selection
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fukuda criteria and Canadian consensus criteria will be the diagnosis criteria for
             patient selection

        Exclusion Criteria:

          -  non inclusion in the above criteria
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DEREK enlander</last_name>
    <role>Principal Investigator</role>
    <affiliation>CFIDS RESEARCH FOUNDATION</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Me/Cfs Center,860 Fifth Avenue</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>derek enlander, MD</last_name>
      <phone>212-794-2000</phone>
      <email>denlander@aol.com</email>
    </contact>
    <investigator>
      <last_name>derek enlander, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 24, 2013</lastchanged_date>
  <firstreceived_date>July 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic fatigue syndrome</keyword>
  <keyword>Karnofsky score</keyword>
  <keyword>supplements</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fatigue</mesh_term>
    <mesh_term>Fatigue Syndrome, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
